Pharmaceuticals stories
OpenText has launched the AI Data Platform to securely unify and manage enterprise data, enhancing AI accuracy and integration across industries.
Asia Pacific's manufacturing surge in semiconductors, pharma, and renewables is transforming industrial property needs, demanding high-tech, specialised facilities.
Elemental Concept has appointed Chris Mitchell as Managing Director APAC to drive its expansion and digital transformation services across the Asia-Pacific region.
Dashmote has raised $6 million to launch DashSalesAI, an AI agent boosting efficiency for field sales teams via mobile platforms like WhatsApp.
XYZ Reality has renewed its ISO 27001 certification, underscoring its commitment to data security in sectors like defence, energy and pharmaceuticals.
Phosphorus Cybersecurity has appointed Sonu Shankar as President and COO following a record quarter driven by demand for automated security across the Internet of Things.
Nebius has awarded over $850,000 in GPU credits to four AI health startups advancing cancer prediction, drug discovery, genomics and diagnostics.
Ransomware attacks on industrial firms surged to 708 in Q1 2025, led by manufacturing, with North America and Europe hardest hit, warns Dragos report.
Amid rising visa hurdles, 23% of UK STEM employers report losing skilled workers abroad, threatening future growth in vital science and tech sectors.
Australia must boost funding and diversify research in quantum computing to harness its benefits and tackle emerging cybersecurity risks, experts warn.
Open ECX has expanded its Salford headquarters by 50%, targeting record GBP £4.6 million sales in 2025 amid sector and international growth.
QAI Ventures has launched Asia's first QuantumAI accelerator in Singapore, aiming to boost startups blending quantum computing and artificial intelligence.
AI adoption is forecast to widen the gender skills gap in the UK's GBP £1 trillion tech sector, raising concerns over equality in emerging industries.
AI use in healthcare is booming, with the market set to hit USD $187bn by 2030, but experts warn of risks from data bias, errors, and weak governance frameworks.
Small business failure risk in Australia has risen 4.5%, outpacing 2.9% growth, hitting micro and young firms hardest amid shifting spending and inflation pressures.
Kyorin Pharmaceutical partners with Elix to enhance drug discovery using Elix Discovery, an AI platform aiming to accelerate research and improve R&D outcomes.
AI-powered predictive risk scores are revolutionising disease prevention by enabling early detection and personalised health interventions before symptoms arise.
Elix and LINC launch the world's first AI drug discovery platform using federated learning, enabling pharma firms to collaborate on models without sharing sensitive data.
UK leads Europe in AI investment with 74% of organisations boosting generative AI spending, driving major cost savings and workforce transformation.
Professor Henrik von Scheel, Industry 4.0 originator, will headline Industrial Transformation Australia 2025 in Sydney, discussing future megatrends shaping manufacturing.